Journal:
Article Title: EXACERBATED MECHANICAL ALLODYNIA IN RATS WITH DEPRESSION-LIKE BEHAVIOR
doi: 10.1016/j.brainres.2008.01.038
Figure Lengend Snippet: A: When examined on postoperative day 7, the immobility time in the forced swimming test (FST) in WKY rats was significantly improved by melatonin (MT, 4 µg, once daily × 7 days) administered into the ACC contralateral to CCI. The melatonin effect was blocked by the broad MT receptor antagonist luzindole [10 µg but not 5 µg (L10, L5)] injected into the same ACC at 10 min before melatonin (4 µg). *P<0.05, as compared with the sham-vehicle (V) group; ++ P<0.01, as compared with the CCI-vehicle group; ## P<0.01, as compared with the CCI-MT group. B. The same melatonin (MT) treatment also improved the immobility time in the horizontal suspension test (HST) in WKY rat on day 7 after CCI. *P#0.05, as compared with sham and CCI-MT groups.
Article Snippet: Melatonin and luzindole (a broad MT receptor antagonist; MT2 > MT1) were purchased from Sigma (St. Louis, MO) and dissolved in 5% ethanol diluted in artificial cerebral spinal fluid (CSF) containing (in mM) NaCl 126, KCl 2.5, NaHCO 3 26, CaCl 2 2, MgCl 2 2, NaH 2 PO 4 1.25, glucose 10 (pH 7.35).
Techniques: Injection